연구동향 분석

Concurrent Chemoradiotherapy Shows Long-Term Survival after Conversion from Locally Advanced to Resectable Hepatocellular Carcinoma

이익재 성진실 김준원 한광협 김자경 김경식 최진섭 박영년 2014년

논문상세정보
인용/피인용
' Concurrent Chemoradiotherapy Shows Long-Term Survival after Conversion from Locally Advanced to Resectable Hepatocellular Carcinoma' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • concurrentchemoradiotherapy
  • hepatic resection
  • hepatocellular carcinoma
  • intra-arterialchemotherapy
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,791 0

0.0%

' Concurrent Chemoradiotherapy Shows Long-Term Survival after Conversion from Locally Advanced to Resectable Hepatocellular Carcinoma' 의 참고문헌

  • 간세포암종의 방사선치료 시 발생하는 간독성에 대한 위험인자의 재고찰
    이익재 Clinical and Molecular Hepatology 12 3 420-428 [2006]
  • Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump
    Atiq OT Cancer 69 920-924 [1992]
  • Treatment of primary liver cancer: response to regional chemotherapy
    Wellwood JM Clin Oncol 5 25-31 [1979]
  • Treatment of non-resectable hepatocellular carcinoma
    Han KH J Gastroenterol Hepatol 17 Suppl 3 S424-S427 [2002]
  • Tolerance of normal tissue to therapeutic irradiation
    Emami B Int J Radiat Oncol Biol Phys 21 109-122 [1991]
  • The significance of ICG-R15 in predicting hepatic toxicity in patients receiving radiotherapy for hepatocellular carcinoma
    Yoon HI LIVER INTERNATIONAL 32 7 1165-1171 [2012]
  • The Efficacy of Hepatic Resection after Neoadjuvant Transarterial Chemoembolization (TACE) and Radiation Therapy in Hepatocellular Carcinoma Greater Than 5 cm in Size
    최새별 Journal of Korean Medical Science 24 2 242-247 [2009]
  • Surgery for small liver cancers
    Makuuchi M Semin Surg Oncol 9 298-304 [1993]
  • Sorafenib in advanced hepatocellular carcinoma
    Llovet JM N Engl J Med 359 378-390 [2008]
  • Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma
    Sandroussi C Transpl Int 2 3 299-306 [2010]
  • Radiotherapeutic Strategies in the Management of Hepatocellular Carcinoma
    Lee IJ ONCOLOGY 81 Suppl I 123-133 [2011]
  • Radiosensitizers in Hepatocellular Carcinoma
    Lee IJ SEMINARS IN RADIATION ONCOLOGY 21 4 303-311 [2011]
  • RADIOTHERAPEUTIC PARAMETERS PREDICTIVE OF LIVER COMPLICATIONS INDUCED BY LIVER TUMOR RADIOTHERAPY
    Lee IJ INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 73 1 154-158 [2009]
  • Prognosis of hepatocellular carcinoma : the BCLC staging classification
    Llovet JM Semin Liver Dis 19 329-338 [1999]
  • Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis
    Han KH Cancer 113 5 995-1003 [2008]
  • Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies
    Ben-Josef E J Clin Oncol 23 8739-8747 [2005]
  • Outcome after curative resection for a huge (>or=10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification
    Choi GH Am J Surg 198 693-701 [2009]
  • Modified RECIST (mRECIST) assessment for hepatocellular carcinoma
    Lencioni R Semin Liver Dis 30 52-60 [2010]
  • Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation
    O’Connor JK Liver Transpl 18 949-954 [2012]
  • Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection
    Pandey D Ann Surg Oncol 14 2817-2823 [2007]
  • Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis
    Majno PE Ann Surg 226 688-701 [1997]
  • Improved survival with resection after transcatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma
    Fan J Dig Surg 15 674-678 [1998]
  • Global cancer statistics, 2002
    Parkin DM CA Cancer J Clin 55 74-108 [2005]
  • Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies
    Dawson LA J Clin Oncol 18 2210-2218 [2000]
  • Efficacy of hepatic resection for hepatocellular carcinomas larger than 10 cm
    Nagano Y World J Surg 29 66-71 [2005]
  • Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
    Cheng AL Lancet Oncol 10 25-34 [2009]
  • Effect of preoperative transcatheter arterial chemoembolization on tumor cell activity in hepatocellular carcinoma
    Huang J Chin Med J (Engl) 113 446-448 [2000]
  • Down-staging of hepatocellular carcinoma via external-beam radiotherapy with subsequent liver transplantation: a case report
    Wigg A Liver Transpl 19 1119-1124 [2013]
  • Cytoreduction and sequential resection: a hope for unresectable primary liver cancer
    Tang ZY J Surg Oncol 47 27-31 [1991]
  • Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma
    Pawlik TM Arch Surg 140 450-457 [2005]
  • Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma
    Seong J INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 43 393-397 [1999]
  • Changes of the liver volume and the Child-Pugh score after high dose hypofractionated radiotherapy in patients with small hepatocellular carcinoma
    김영일 Radiation oncology journal 30 4 189-196 [2012]
  • Challenge and Hope in Radiotherapy of Hepatocellular Carcinoma
    성진실 Yonsei Medical Journal 50 5 601-612 [2009]
  • An application of dose volume histograms to the treatment of intrahepatic malignancies with radiation therapy
    Lawrence TS Int J Radiat Oncol Biol Phys 19 1041-1047 [1990]